Received Jul 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | UNK | Y019158 | OT / LA |
Reports swollen lymph node and raised irregular red rash i; raised irregular red rash in front of armpit on left side approx 3 x 3 inches appeared the day after.; This spontaneous report was received from a consumer via company representative and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 07-Jul-2025, the patient was vaccinated with Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) (lot #Y019158 which has been verified to be a valid number, expiration date reported an validated as 20-May-2026), administered by Intramuscular route in left arm (deltoid), as a prophylaxis. On 08-Jul-2025 (the day after), the patient experienced swollen lymph node and raised irregular red rash in front of armpit on left side approx. 3 x 3 inches appeared. At the reporting time, the outcome of swollen lymph nodes and red rash was unknown. The causal relationship between the events and Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) was not provided.